Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-036271
Filing Date
2021-09-16
Accepted
2021-09-16 16:05:19
Documents
1
Period of Report
2021-09-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3098
  Complete submission text file 0000899243-21-036271.txt   4819
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Issuer) CIK: 0001117480 (see all company filings)

EIN.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1792 BELL TOWER LANE SUITE 222 WESTON FL 33326
Business Address 1792 BELL TOWER LANE SUITE 222 WESTON FL 33326 954-315-3660
CANTEX PHARMACEUTICALS, INC. (Reporting) CIK: 0001374961 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35867 | Film No.: 211257996
SIC: 2834 Pharmaceutical Preparations